The man claims that Novo Nordisk was aware of the risk and should have told patients that Ozempic may increase a patients chance of becoming blind from NAION
Patients may discontinue treatment due to the inability to tolerate these side effects
This can result in individuals eating less and, over time, losing weight
They are distinct molecules that work through distinct mechanisms, and treating them as simple substitutes for each other misses critical pharmacological nuances that affect safety and efficacy
In line with FDA guidance that clinicians monitor for new or worsening depression, suicidal thoughts, or unusual changes in mood during GLP-1 RA treatment [46], brief psychological screening should be incorporated at baseline and repeated at intervals during treatment at weeks 6, 12, and 24, and then at least every six months